Skip to main content

Products

Comprehensive catalog of pharmaceutical solutions. Browse categories and send inquiries directly.

Connect With Us

All Products (364)

Clear all filters
Clear all filters

Cobolimab

Immunotherapy (Investigational Checkpoint)

Therapeutic Category

Immunotherapy (Investigational Checkpoint)

Oncology Type

Both (Solid & Hematologic)

Drug Class / Mechanism

TIM-3 / LAG-3 / TIGIT Inhibitor

Danusertib

Targeted Therapy (Investigational)

Therapeutic Category

Targeted Therapy (Investigational)

Oncology Type

Both (Solid & Hematologic)

Drug Class / Mechanism

Polo-Like / Aurora Kinase Inhibitor

Domvanalimab

Immunotherapy (Investigational Checkpoint)

Therapeutic Category

Immunotherapy (Investigational Checkpoint)

Oncology Type

Both (Solid & Hematologic)

Drug Class / Mechanism

TIM-3 / LAG-3 / TIGIT Inhibitor

Eftilagimod Alfa

Immunotherapy (Investigational Checkpoint)

Therapeutic Category

Immunotherapy (Investigational Checkpoint)

Oncology Type

Both (Solid & Hematologic)

Drug Class / Mechanism

TIM-3 / LAG-3 / TIGIT Inhibitor

Enmd-2076

Targeted Therapy (Investigational)

Therapeutic Category

Targeted Therapy (Investigational)

Oncology Type

Both (Solid & Hematologic)

Drug Class / Mechanism

Polo-Like / Aurora Kinase Inhibitor

Etigilimab

Immunotherapy (Investigational Checkpoint)

Therapeutic Category

Immunotherapy (Investigational Checkpoint)

Oncology Type

Both (Solid & Hematologic)

Drug Class / Mechanism

TIM-3 / LAG-3 / TIGIT Inhibitor

Favezelimab

Immunotherapy (Investigational Checkpoint)

Therapeutic Category

Immunotherapy (Investigational Checkpoint)

Oncology Type

Both (Solid & Hematologic)

Drug Class / Mechanism

TIM-3 / LAG-3 / TIGIT Inhibitor

Ilorasertib

Targeted Therapy (Investigational)

Therapeutic Category

Targeted Therapy (Investigational)

Oncology Type

Both (Solid & Hematologic)

Drug Class / Mechanism

Polo-Like / Aurora Kinase Inhibitor

Ociperlimab

Immunotherapy (Investigational Checkpoint)

Therapeutic Category

Immunotherapy (Investigational Checkpoint)

Oncology Type

Both (Solid & Hematologic)

Drug Class / Mechanism

TIM-3 / LAG-3 / TIGIT Inhibitor

Plinabulin

Supportive Care (Investigational Growth Factor Alternative)

Therapeutic Category

Supportive Care (Investigational Growth Factor Alternative)

Oncology Type

Both (Solid & Hematologic)

Drug Class / Mechanism

Tubulin-Binding Agent / GEF-H1 Activator

Rigosertib

Targeted Therapy (Investigational)

Therapeutic Category

Targeted Therapy (Investigational)

Oncology Type

Both (Solid & Hematologic)

Drug Class / Mechanism

Polo-Like / Aurora Kinase Inhibitor

Rilvegostomig

Immunotherapy (Investigational Checkpoint)

Therapeutic Category

Immunotherapy (Investigational Checkpoint)

Oncology Type

Both (Solid & Hematologic)

Drug Class / Mechanism

TIM-3 / LAG-3 / TIGIT Inhibitor